COVID-19 in the IBD Population: The Need for Correct Nomenclature
Ashkan Rezazadeh Ardabili(Maastricht University Medical Centre), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Rob H. Creemers(Zuyderland Medisch Centrum)
Cited by 1
Related Papers
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
|Nature Clinical Practice Gastroenterology & Hepatology|2007|129
Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease
|Inflammatory Bowel Diseases|2012|102
Dose-Dependent Influence of 5-Aminosalicylates on Thiopurine Metabolism
|The American Journal of Gastroenterology|2007|101
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives
|Journal of Crohn s and Colitis|2017|94
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
|Alimentary Pharmacology & Therapeutics|2020|87